A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: A single center report

Transplantation

Volumn 72, Issue 6, 2001, Pages 1091-1097

  Jain, A ^a,b   Kashyap, R ^a   Dodson, F ^a   Kramer, D ^c   Hamad, I ^a   Khan, A ^a   Eghestad, B ^a   Starzl, T E ^a   Fung, J J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0035959981     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200109270-00019     Document Type: Article

References (26)

1. Randomized trial comparing tacrolimus and cyclosporin in prevention of liver allograft rejection
2. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation
3. Safety, efficacy and pharmacokinetics of mycophenolate mofetil in liver transplantation: Results of multicenter, randomized, double blind trial-abstract 103
4. The mechanism of action of cyclosporin A and FK506
5. Liver, kidney, and thoracic organ transplantation under FK506
6. Current perspective on immunosuppression used in liver transplantation with emphasis on neurotoxicity
7. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443
8. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
9. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients
10. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: An interim report
11. Banff schema for grading liver allograft rejection: An international consensus document
12. Detection of early antigenemia (pp65) in peripheral blood leucocytes and preemptive therapy for cytomegalovirus infection in liver transplant recipients
13. Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: A cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients
14. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: A prospective trial of cyclosporine and tacrolimus
15. Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients
16. Use of mycophenolate mofetil for tacrolimus related chronic nephrotoxicity in liver transplant recipients
17. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil
18. Tacrolimus and mycophenolate mofetil in clinical liver transplantation: Experience with a steroid-sparing concept
19. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil
20. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation
21. Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil
22. Tacrolimus-based immunesuppression after liver transplantation: A randomised study comparing dual versus triple low-dose oral regimens
23. A prospective randomized trial of mycophenolate mofetil with Neoral or tacrolimus after orthotopic liver transplantation
24. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study
25. Mycophenolate mofetil as induction therapy after liver transplantation